These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24578237)

  • 1. Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm.
    Van Buskirk GA; Asotra S; Balducci C; Basu P; DiDonato G; Dorantes A; Eickhoff WM; Ghosh T; González MA; Henry T; Howard M; Kamm J; Laurenz S; MacKenzie R; Mannion R; Noonan PK; Ocheltree T; Pai U; Poska RP; Putnam ML; Raghavan RR; Ruegger C; Sánchez E; Shah VP; Shao ZJ; Somma R; Tammara V; Thombre AG; Thompson B; Timko RJ; Upadrashta S; Vaithiyalingam S;
    AAPS PharmSciTech; 2014 Jun; 15(3):665-93. PubMed ID: 24578237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
    O'Connor TF; Yu LX; Lee SL
    Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transdermal systems whitepaper incorporating current chemistry, manufacturing and controls (CMC) development principles.
    Van Buskirk GA; Arsulowicz D; Basu P; Block L; Cai B; Cleary GW; Ghosh T; González MA; Kanios D; Marques M; Noonan PK; Ocheltree T; Schwarz P; Shah V; Spencer TS; Tavares L; Ulman K; Uppoor R; Yeoh T
    AAPS PharmSciTech; 2012 Mar; 13(1):218-30. PubMed ID: 22215291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
    Steinwandter V; Herwig C
    PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of benchmarking in the development of biopharmaceutical products.
    Giffin M; McLeish S
    Biotechnol Annu Rev; 2003; 9():279-84. PubMed ID: 14650932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies.
    Demmon S; Bhargava S; Ciolek D; Halley J; Jaya N; Joubert MK; Koepf E; Smith P; Trexler-Schmidt M; Tsai P
    Biologicals; 2020 Sep; 67():9-20. PubMed ID: 32665104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive Manufacturing with 3D Printing: Progress from Bench to Bedside.
    Rahman Z; Barakh Ali SF; Ozkan T; Charoo NA; Reddy IK; Khan MA
    AAPS J; 2018 Sep; 20(6):101. PubMed ID: 30209693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System.
    Rolke R; Ramnarine E; Vinther A; Sawant A
    PDA J Pharm Sci Technol; 2020; 74(2):286-288. PubMed ID: 32179712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical Report No. 38. Manufacturing chromatography systems postapproval changes (ChromPAC): chemistry, manufacturing, and controls documentation.
    PDA Manufacturing Chromatography Systems PAC Taskforce
    PDA J Pharm Sci Technol; 2006 Mar; 60(1 Suppl TR38):1-29. PubMed ID: 16696189
    [No Abstract]   [Full Text] [Related]  

  • 16. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solving the Global Continual Improvement and Innovation Challenge: How an Effective Pharmaceutical Quality System Can Transform Post-Approval Change Management.
    Vinther A; Ramnarine E
    PDA J Pharm Sci Technol; 2019; 73(5):517-521. PubMed ID: 31420505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Badman C; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):779-80. PubMed ID: 25501284
    [No Abstract]   [Full Text] [Related]  

  • 20. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
    J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.